FDA MedWatch - Outbreak Investigation of Extensively Drug-Resistant Salmonella: Moringa Powder (February 2026)

If your email program has trouble displaying this email, view as a webpage.

TOPIC: Outbreak Investigation of Extensively Drug-Resistant Salmonella: Moringa Powder (February 2026). Do Not eat or Sell Certain Lots of Rosabella-Brand Moringa Powder Capsules. FDA’s Investigation is Ongoing

AUDIENCE: Consumer, Health Care Professional, Pharmacy, Infectious Disease

ISSUE: The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Salmonella Newport infections linked to Rosabella-brand moringa powder capsules distributed by Ambrosia Brands LLC.

Based on epidemiological information collected by CDC, a total of seven people infected with the outbreak strain of Salmonella have been reported from seven states. Illnesses started on dates ranging from November 7, 2025, to January 8, 2026. Of the three people interviewed, three (100%) reported eating Rosabella-brand moringa powder capsules. There have been three hospitalizations, and no deaths have been reported. The Salmonella strain associated with this outbreak is resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections. For healthcare providers, learn more about this strain’s resistance and get guidance for diagnosing and treating infections.

FDA has recommended that Ambrosia Brands LLC recall all Rosabella-brand moringa powder capsules from the market and the firm has agreed to conduct a recall of certain lots.

Please see the table on the alert for a complete list of lot codes and expiration dates.

The product was sold at multiple online stores including eBay, TikTok shop, Amazon, Shein, and the Tryrosabella.com online store. 

For more information about this alert, click on the red button "Read Recall" below.

BACKGROUND: The product being recalled is sold as dietary supplement capsules.

RECOMMENDATIONS:

For Consumers 

• Consumers and retailers who purchased Rosabella-brand moringa powder capsules should check the bottle, and if your bottle has an expiration date in 2027, check for the lot codes listed below. If your bottle has one of these lot codes, you should not eat, sell, or distribute the product and should throw this product and its container away or return it to the place of purchase.

• Consumers and retailers who purchased or received certain lots of Rosabella-brand moringa powder capsules should carefully clean and sanitize any surfaces or containers that the product touched. Follow FDA’s safe handling and cleaning advice and use extra care in cleaning and sanitizing any surfaces and containers that may have come in contact with this product to reduce the risk of cross-contamination.  

• Contact your healthcare provider immediately if you think you may have developed symptoms of a Salmonella infection after consuming Rosabella-brand moringa powder capsules.

For Health Care Professionals

• The Salmonella strain associated with this outbreak is resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections. 

• Learn more about this strain’s resistance and get guidance for diagnosing and treating infections.

Health care professionals and consumers are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.

Follow us on X at @FDAMedWatch